Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J
Institute of Clinical Chemistry II, Medical School Hannover, Germany.
Crit Care Med. 2000 Aug;28(8):2793-8. doi: 10.1097/00003246-200008000-00019.
To evaluate whether plasma concentrations of procalcitonin (PCT), interleukin-6 (IL-6), protein complement 3a (C3a), leukocyte elastase (elastase), and the C-reactive protein (CRP) determined directly after the clinical onset of sepsis or systemic inflammatory response syndrome (SIRS) discriminate between patients suffering from sepsis or SIRS and predict the outcome of these patients.
Prospective study.
Medical intensive care unit at a university hospital.
Twenty-two patients with sepsis and 11 patients with SIRS.
The plasma concentrations of PCT, C3a, and IL-6 obtained < or =8 hrs after clinical onset of sepsis or SIRS but not those of elastase or CRP were significantly higher in septic patients (PCT: median, 16.8 ng/mL, range, 0.9-351.2 ng/mL, p = .003; C3a: median, 807 ng/mL, range, 422-4788 ng/mL, p < .001; IL-6: median, 382 pg/mL, range, 5-1004 pg/mL, p = .009, all Mann-Whitney rank sum test) compared with patients suffering from SIRS (PCT: median, 3.0 ng/mL, range, 0.7-29.5 ng/mL; C3a: median, 409 ng/mL, range, 279566 ng/mL; IL-6: median, 98 pg/mL, range, 23-586 pg/mL). The power of PCT, C3a, and IL-6 to discriminate between septic and SIRS patients was determined in a receiver operating characteristic analysis. C3a was the best variable to differentiate between both populations with a maximal sensitivity of 86% and a specificity of 80%. An even better discrimination (i.e., a maximal sensitivity of 91% and a specificity of 80%) was achieved when PCT and C3a were combined in a "sepsis score." C3a concentrations also helped to predict the outcome of patients. Based on the sepsis score, a logistic regression model was developed that allows a convenient and reliable determination of the probability of an individual patient to suffer from sepsis or SIRS.
Our data show that the determination of PCT, IL-6, and C3a is more reliable to differentiate between septic and SIRS patients than the variables CRP and elastase, routinely used at the intensive care unit. The determination of PCT and C3a plasma concentrations appears to be helpful for an early assessment of septic and SIRS patients in intensive care.
评估脓毒症或全身炎症反应综合征(SIRS)临床发病后即刻测定的血浆降钙素原(PCT)、白细胞介素-6(IL-6)、补体蛋白3a(C3a)、白细胞弹性蛋白酶(弹性蛋白酶)和C反应蛋白(CRP)浓度能否区分脓毒症或SIRS患者,并预测这些患者的预后。
前瞻性研究。
大学医院的医学重症监护病房。
22例脓毒症患者和11例SIRS患者。
脓毒症或SIRS临床发病后≤8小时测得的血浆PCT、C3a和IL-6浓度,而非弹性蛋白酶或CRP浓度,在脓毒症患者中显著更高(PCT:中位数为16.8 ng/mL,范围为0.9 - 351.2 ng/mL,p = 0.003;C3a:中位数为807 ng/mL,范围为422 - 4788 ng/mL,p < 0.001;IL-6:中位数为382 pg/mL,范围为5 - 1004 pg/mL,p = 0.009,均采用曼-惠特尼秩和检验),与SIRS患者相比(PCT:中位数为3.0 ng/mL,范围为0.7 - 29.5 ng/mL;C3a:中位数为409 ng/mL,范围为279 - 566 ng/mL;IL-6:中位数为98 pg/mL,范围为23 - 586 pg/mL)。在受试者工作特征分析中确定了PCT、C3a和IL-6区分脓毒症和SIRS患者的效能。C3a是区分这两类人群的最佳变量,最大灵敏度为86%,特异性为80%。当将PCT和C3a合并为“脓毒症评分”时,区分效果更佳(即最大灵敏度为91%,特异性为80%)。C3a浓度也有助于预测患者的预后。基于脓毒症评分,建立了一个逻辑回归模型,可方便可靠地确定个体患者患脓毒症或SIRS的概率。
我们的数据表明,与重症监护病房常规使用变量CRP和弹性蛋白酶相比,测定PCT、IL-6和C3a在区分脓毒症和SIRS患者方面更可靠。测定血浆PCT和C3a浓度似乎有助于对重症监护中的脓毒症和SIRS患者进行早期评估。